AgeX Therapeutics Reports Fourth Quarter and Annual 2022 Financial Results

AgeX Therapeutics, Inc. , a biotechnology company developing therapeutics for human aging and regeneration, reported its financial and operating results for fourth quarter and the full year ended... | March 31, 2023

Related Keywords

United States ,American , ,Twitter ,Agex Therapeutics Inc ,Lifemap Sciences Inc ,Paycheck Protection Program ,National Institutes Of Health ,Facebook ,Youtube ,Linkedin ,Exchange Commission ,Lifemap Sciences ,Agex Therapeutics ,Juvenescence Limited ,National Institutes ,Accounting Standards Update ,Financial Statements Going Concern ,Annual Report ,Private Securities Litigation Reform Act ,Ended December ,Secured Note ,Nc Stock Exchange ,News ,Information ,Press Release ,Ngex ,Biotechnology ,Company ,Developing ,Herapeutics ,Or ,Human ,Aging ,End ,Eported ,Its ,Financial ,Operating ,Results ,Fourth ,Quarter ,The ,Bull ,Ear Age Us00848h1086 ,